The EO marks a shift toward individualized decision‑making in childhood vaccination.
Vaccines
Centers for Medicare & Medicaid Services moves to strengthen oversight of Applied Behavior Analysis services and reduce fraud, waste, and abuse.
The new White House policy bans federal funding for dangerous gain of function research and reshapes oversight for high-risk science.
During a heated testimony before the House Committee on Ways and Means, the HSS secretary criticized the task force for a “lackadaisical” approach over two decades.
The ruling temporarily reinstates former ACIP members removed by Kennedy and vacates all of the new committee’s policy recommendations.
![What [the heck] is going on with vaccine policy in America?](https://www.grip.globalrelay.com/wp-content/uploads/2026/02/G-Vaccine-signage-2259640793.jpg?w=1024)
Our experts argue that the government’s new approach could stymie R&D and brings uncertainty to the business of producing and offering vaccines.
The regulator is allowing the pharma giant’s revised biologics licensed application to proceed to review.
The FDA issued an extremely rare refuse-to-file letter related to Moderna’s new mRNA flu vaccine.